Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preliminary Evaluation of [64Cu] Macrin in Healthy Individuals and Subjects With Cardiovascular Disease, Sarcoidosis and Malignancy.

NCT04843891 is registered in ClinicalTrials.gov with Ralph Weissleder, MD as lead sponsor.

NCT NCT04843891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04843891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preliminary Evaluation of [64Cu] Macrin in Healthy Individuals and Subjects With Cardiovascular Disease, Sarcoidosis and Malignancy.
Lead sponsor
Ralph Weissleder, MD
Phase
Phase 1
Overall status
Unknown status
Start date
September 6, 2021
Completion date
April 5, 2023
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, cardiovascular diseases, sarcoid